‘We’re living in a pigsty’: Morristown seniors vent to housing authority about conditions, and privatization
Jul 21, 2023GE Profile Clearview PHNT10 Smart Air Conditioner
Jul 13, 2023Global Blood Coagulation Analyzer Market Size and Forecast
Aug 18, 2023Comparison of subretinal aflibercept vs ranibizumab vs bevacizumab in the context of PPV, pneumatic displacement with subretinal air and subretinal tPA in naïve submacular haemorrhage secondary to nAMD. “The Submarine Study”
Jul 27, 2023Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond
Aug 02, 2023Bioimpedance Analyzers Market worth $927 million
News provided by
02 Aug, 2023, 16:15 BST
Share this article
CHICAGO, Aug. 2, 2023 /PRNewswire/ -- In the near future, the bioimpedance analyzers industry is poised for substantial growth and innovation. Advancements in sensor technology and data processing are expected to lead to more accurate and user-friendly devices, while integration with smartphones and wearables may become increasingly common. Bioimpedance analyzers are likely to find expanded applications in healthcare, aiding in the diagnosis and management of various health conditions. Moreover, their popularity in the fitness and wellness sectors is expected to rise, empowering individuals to monitor body composition changes and set personalized health goals. As the industry expands, regulatory bodies may establish more specific guidelines, and increased market competition could drive further advancements and accessibility of these devices.
Bioimpedance Analyzers Market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government in promoting healthy lifestyle to curb obesity, growing number of gyms and wellness centers, strong presence of local players in China, and innovation in bioimpedance analyzers technology by integrating with wearable devices.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144536297
Browse in-depth TOC on "Bioimpedance Analyzers Market"
126 - Tables32 - Figures170 - Pages
Bioimpedance Analyzers Market Scope:
Report Coverage
Details
Market Revenue in 2023
$564 million
Estimated Value by 2028
$927 million
Growth Rate
Poised to grow at a CAGR of 10.4%
Market Size Available for
2021–2028
Forecast Period
2023–2028
Forecast Units
Value (USD Million)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Product, Modality, Usage Type, Application, and End User
Geographies Covered
North America, Europe, Asia Pacific, Rest of the World
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Integration with wearable devices
Key Market Drivers
Increasing prevalence of lifestyle diseases
Multi-frequency bioimpedance analyzers segment is expected to account for the largest share in 2022.
The bioimpedance analyzers market, by product, has been segmented into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to the accurate and precise measurements as compared to single and dual frequency bioimpedance analyzers.
The professional grade bioimpedance analyzers segment held the largest market share in the bioimpedance analyzers market.
By usage type, the global bioimpedance analyzers market is broadly segmented into into consumer-grade and professional-grade bioimpedance analyzers. The professional grade bioimpedance analyzers segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to various factors, such as rising fitness awareness, growing number of obese population, and the growing number of hospitals which is the major end user for professional-grade bioimpedance analyzers.
North America dominates the global bioimpedance analyzers market
Based on the region, the bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America market is driven by rising adoption of bioimpedance analyzers by atheletes to track progress and fitness initiatives by government and local groups. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. The presence of a large population base, strong presence of local players, and increasing rate of obesity are some of the major factors driving the growth of this regional market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=144536297
Bioimpedance Analyzers Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
Major players in bioimpedance analyzers market include OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), and seca GmbH & Co. KG (Germany).
Recent Developments:
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=144536297
Bioimpedance Analyzers Market Advantages:
Related Reports:
Active Pharmaceutical Ingredient Market - Global Forecasts to 2027
Bariatric Surgery Devices Market - Global Forecasts to 2027
Minimally Invasive Surgical Instruments Market - Global Forecasts to 2026
Metabolomics Market - Global Forecasts to 2025
Cardiac Monitoring Devices Market - Global Forecasts to 2025
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Insight: https://www.marketsandmarkets.com/ResearchInsight/bioimpedance-analyzer-market.aspVisit Our Website: https://www.marketsandmarkets.com/Content Source: https://www.marketsandmarkets.com/PressReleases/bioimpedance-analyzer.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
SOURCE MarketsandMarkets
MarketsandMarkets